mk 0663 has been researched along with Exanthema in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Devkota, R; Dhungel, A; Dongol, A; Pandey, A; Parajuli, S | 1 |
| Caralli, ME; De Barrio Fernández, M; Pelta Fernández, R; Rojas Pérez-Ezquerra, P; Seoane Rodríguez, M | 1 |
| Lammintausta, K; Mäkelä, L | 1 |
3 other study(ies) available for mk 0663 and Exanthema
| Article | Year |
|---|---|
Etoricoxib Induced Toxic Epidermal Necrolysis in a case of Systemic Lupus Erythematosus: A Case Report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Etoricoxib; Exanthema; Female; Humans; Lupus Erythematosus, Systemic; Stevens-Johnson Syndrome | 2022 |
Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Drug Eruptions; Etoricoxib; Exanthema; Female; Humans; Middle Aged; Osteoarthritis; Patch Tests; Pyridines; Sulfones | 2016 |
Etoricoxib-induced acute generalized exanthematous pustulosis.
Topics: Acute Disease; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Exanthema; Humans; Male; Middle Aged; Patch Tests; Pyridines; Skin; Skin Diseases, Vesiculobullous; Sulfones | 2008 |